Teva, Endo and more back on the hook in San Francisco opioid trial

A San Francisco opioid lawsuit against multiple drugmakers and pharmacies, including Teva Pharmaceutical and Walgreens, is set to proceed after a federal judge rejected the companies’ bid to delay the case.

In December, Teva, Endo International, Par Pharmaceutical and AbbVie’s Allergan moved to stay all claims against them in the suit, filed in the United States District Court for the Northern District of California, citing a recent victory in the California Superior Court for Orange County.